TCGA analysis identifies distinct genomic features of oncogenic progression and outcome associated with hemizygous PTEN loss tumors (2021)
- Authors:
- USP affiliated authors: REIS, RODOLFO BORGES DOS - FMRP ; SQUIRE, JEREMY ANDREW - FMRP ; DUTRA, WILLIAM LAUTERT - FMRP ; SOUZA, LUIZ PAULO CHAVES DE - FMRP
- Unidade: FMRP
- Subjects: GENES SUPRESSORES DE TUMOR; MUTAÇÃO GENÉTICA; CARCINOGÊNESE
- Keywords: PanCancer; Haploinsufficiency; Tumor supressor gene
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Publisher: Sociedade Brasileira de Genética - SBG
- Publisher place: [Ribeirão Preto]
- Date published: 2021
- Source:
- Título: Resumos
- Conference titles: Congresso Brasileiro de Genética = Brazilian Congress of Genetics
-
ABNT
MELO, Camila Morais et al. TCGA analysis identifies distinct genomic features of oncogenic progression and outcome associated with hemizygous PTEN loss tumors. 2021, Anais.. [Ribeirão Preto]: Sociedade Brasileira de Genética - SBG, 2021. Disponível em: https://www.sbg.org.br/anais. Acesso em: 09 out. 2024. -
APA
Melo, C. M., Vidotto, T., Dutra, W. L., Souza, L. P. C. de, Reis, R. B. dos, & Squire, J. A. (2021). TCGA analysis identifies distinct genomic features of oncogenic progression and outcome associated with hemizygous PTEN loss tumors. In Resumos. [Ribeirão Preto]: Sociedade Brasileira de Genética - SBG. Recuperado de https://www.sbg.org.br/anais -
NLM
Melo CM, Vidotto T, Dutra WL, Souza LPC de, Reis RB dos, Squire JA. TCGA analysis identifies distinct genomic features of oncogenic progression and outcome associated with hemizygous PTEN loss tumors [Internet]. Resumos. 2021 ;[citado 2024 out. 09 ] Available from: https://www.sbg.org.br/anais -
Vancouver
Melo CM, Vidotto T, Dutra WL, Souza LPC de, Reis RB dos, Squire JA. TCGA analysis identifies distinct genomic features of oncogenic progression and outcome associated with hemizygous PTEN loss tumors [Internet]. Resumos. 2021 ;[citado 2024 out. 09 ] Available from: https://www.sbg.org.br/anais - The role of somatic mutations on the immune response of the tumor microenvironment in prostate cancer
- Analysis of the relationships between ZEB1, PTEN loss, TMPRSS2-ERG fusion and immune response biomarkers in Prostate Cancer
- Impact of CDK12 loss on immune response in TCGA prostate tumors
- Analysis of the impact of ZEB1 expression on pathway enrichment and immune cell abundance in prostate cancer
- Risk stratification of prostate cancer through quantitative assessment of PTEN loss (qPTEN)
- Quantitative measurement of PTEN loss improves risk assessment in prostate cancer
- Epithelial–mesenchymal transition signaling and prostate cancer stem cells: emerging biomarkers and opportunities for precision therapeutics
- Differential gene expression related to TMPRSS2-ERG fusion, CDK12, RB1, TP53, AR and ZEB1 based on transcriptomic analysis of the TCGA PRAD cohort
- Trannscriptomics and immune response in human cancer
- A expressão dos marcadores de transição epitélio-mesenquimal SNAI1 e o ZEB1 resulta em alterações transcricionais para promover progressão tumoral e evasão imune no câncer de próstata
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
